RGT 7.94% 29.0¢ argent biopharma limited

Ann: MXC Cannabis Research Permit Granted for RMIT Programs, page-2

  1. 9 Posts.
    lightbulb Created with Sketch. 1
    MXC-Cannabis-Research-Permit-Granted-for-RMIT-Programs.PDF

    "...The receipt of a Permit enables MXC to proceed with botanical research projects in collaboration
    with RMIT University which includes cultivating and breeding strains in order to test against cancer
    cells, with the aim of optimising efficacy. Strains will be screened for anticancer activity, initially
    melanoma and prostate cancers.
    The botanical research will leverage existing MGC Pharma IP and focus on identifying new
    cannabinoids and formulas to find new treatments. Initially the research analysis is to specifically
    target efficacy against melanoma, prostate and other cancer cells."

    Looking forward to seeing the results of research!
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.